#MedSky-did you go to a conference this year? What if you donated the same amount of 💵 that you spent on ☕ to a food charity?
#SFN25 #AANAM2025 #CHS2025 #WCN2025 #EAES2025 #AAIC2025 #AANAM #PNS2025 #AACAP25 #APAAM25 #WCP25 #EPA2025 #IMHC25 #ICCAP #AAMC25
#HCWvsHunger #BrainDocsUnite
On behalf of @istaart.bsky.social Design and Data Analytics PIA: We’ve compiled a new Resource Page on the ISTAART website highlighting key websites and tools shared during our #DaDA PIA Day at #AAIC2025.
Check it out (PIA members only): urldefense.com/v3/__https:/... (File Categories>Resources)
Alzheimer's disease may not start in your brain.
New research from #AAIC2025: Disease pathology appears in the GUT before the brain—and travels upward via the vagus nerve.
For APOE4 carriers, that highway runs faster.
A thread 🧵👇
youtu.be/adrNV1C3Y5k
FTD Disorders Registry data was featured in several posters at the Alzheimer’s Association International Conference this year in Toronto.
Learn more and view the posters: ftdregistry.org/press/regist...
#AAIC2025 #endFTD
Can antivirals against herpes treat early-stage Alzheimer's? At #AAIC2025, researchers presented data from a clinical trial showing no effect.
My latest for @beingpatient.bsky.social
beingpatient.com/cold-sore-vi...
1/6
New 4-year Alzheimer's data:
- 69% of early patients: zero decline
- APOE4/4 carriers: 20% biomarker drop with oral pill
- Benefits double over time (not plateau)
- Start early = 27% better outcome
Not reversing damage, but finally bending the curve.
#AAIC2025 #Alzheimers #APOE4
youtu.be/DipVwic6pPI
Got to love a @profrobhoward.bsky.social take down!
#AAIC2025
Sahil presented earlier this month at #AAIC2025 in Toronto @alzassociation.bsky.social
This work was supported by BrightFocus & NIH Aging and aims to advance #precisionmedicine in #neurodegeneration through the development of small molecule probes for #epichaperome imaging in #Alzheimers.
Researchers from the Wisconsin Alzheimer’s Institute made a strong showing at #AAIC2025, sharing insights into clinical care, research for everyone, and how the WRAP study is powering findings worldwide. Their dedication is shaping the future of Alz research. #WAI #UWAlz #AlzheimersResearch
Many Canadians wait years for a #dementia diagnosis due to complex care pathways. Through our CORTEX program, we partner with communities to test + co-develop #neurotech. So far, 1430 reached via the Canadian Dementia Registry.
Learn more from our #AAIC2025 poster: braininstitute.ca/docs/AAIC202...
🔬 Lors du dernier congrès international #AAIC2025 de Toronto, plusieurs communications scientifiques ont rappelé un fait préoccupant : l’exposition au plomb pourrait affecter la mémoire et augmenter le risque d’Alzheimer.
📌En savoir plus : alzheimer-recherche.org/recherche-et...
We just got back from #AAIC2025 where we were inspired by the passion of Alzheimer's researchers. We're excited to work with this community to advance #Alzheimer's research and ultimately improve outcomes. Explore our takeaways from AAIC:
www.nautilus.bio/blog/excitem...
#AlzheimersDisease#Tau
What's one lifestyle change you're excited to try or reinforce for brain health? US-POINTER Trial Results Revealed that lifestyle interventions significantly improve cognition in Seniors!
www.alz.org/getmedia/5d1...
#USPOINTER, #aaic2025 #brainhealth #AlzheimersPrevention #grandparentspharmacist
ALZpath Advisory Board
What a week at #AAIC2025 🧠
ALZpath was proud to connect with global leaders in Alzheimer’s disease care and our Advisory Board.
@alzassociation.bsky.social released new Blood-Based Biomarker Guidelines—congrats to Dr. Henrik Zetterberg, our Distinguished Scientific Advisor, for his contribution.
Red weights next to a model of a brain. Text reads: Breaking News Dispatch: New Discoveries in Alzheimer's Prevention, Diagnosis, and Treatment
From lifestyle changes that protect memory and cutting-edge blood tests to evidence that past lead exposure can impact brain health decades later—major findings at #AAIC2025 are shaping the future of Alzheimer's prevention, diagnosis, and care.
Learn more: bit.ly/3HhDLnO
An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer's disease, researchers said. #AAIC2025
www.medpagetoday.com/meetingcover...
Our team had a wonderful time attending AAIC 2025 last week and enjoyed presenting their research and connecting with colleagues.
@alzassociation.bsky.social #AAIC2025
(2/2)
Our team had a wonderful time attending AAIC 2025 last week and enjoyed presenting their research and connecting with colleagues.
@alzassociation.bsky.social #AAIC2025
(1/2)
Had an amazing time at #AAIC2025 this year!
🌟 Really enjoyed connecting with some wonderful people 🤝
and soaking up a brilliant range of talks — from sex differences in FTD to sensory abnormalities in dementia 🧠
Huge thanks to everyone that made it happen 🙏
Can’t wait for next year already! 🎉
Wrapped up an inspiring week at #AAIC25 in Toronto—grateful for the science, connections, conversations, and community. Left with new ideas, new friends, and new questions to answer! 🧬🧠
#ENDALZ #AAIC2025 #FossatiLab
Thank you to #AAIC25 for another amazing conference on #AlzheimersDisease research! Had a great time presenting new work from the lab, reconnecting with old labmates and mentors, and meeting new colleagues! #AAIC2025 #BrownMICAADStudy
The clinical benefits of donanemab (Kisunla) continued over 3 years in people with early symptomatic Alzheimer's disease, data from the long-term extension of the TRAILBLAZER-ALZ 2 trial suggested. #AAIC2025
www.medpagetoday.com/meetingcover...
📢 Are you a dementia researcher in the UK? Or one of the talented teams that took part in the #BioHermes001 Data Challenge? @kalliverse.bsky.social has some exciting news to share with you — all the way from the AAIC 2025 in Toronto!
More updates coming soon. 🧠
#AAIC2025 #BioHermes002
Thank you #AAIC2025 for your great support for our talented young scientists who are interested in Alzheimer’s disease. Congratulations on all Poster competition winners, including my fantastic PhD student, Tae Yeon Kim. So proud of you!!!
Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein inhibitor obicetrapib relative to placebo in a large phase III trial. #AAIC2025
www.medpagetoday.com/meetingcover...
Bumping into former PhD students at #AAIC2025 and planning our future collaborations between the UK and Thailand
Thank you, #AAIC2025! We loved connecting with researchers, clinicians & advocates at our booth. Your curiosity and commitment to advancing #FTD understanding inspire us. Let’s keep moving toward earlier diagnosis and better care. #FTDRegistry #FTDResearch #EndFTD
🧠✨ That’s a wrap on #AAIC2025!
What an inspiring week! We are proud to be part of this community of researchers and biotech innovators who are advancing brain research with smart science. Ready to keep pushing the boundaries together?
#NeuroscienceInnovation #DataDrivenDiscovery #AlzheimersResearch
This has been a fantastic meeting! Made new connections, caught up with former colleagues, and learned so much from thought leaders and innovators in AD drug development. Cheers to all and safe travels home. #AAIC25 #AAIC2025
Dr. George Ioannidis presenting at @alzassociation.bsky.social #AAIC2025! Our poster highlights how Cognitive Groove significantly expanded #lifespace mobility in older adults with mild cognitive impairment (MCI). Let’s make brain health the goal! 🧠💃🏽🌍
